19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

placement <strong>of</strong> a shunt during the same operation for closure <strong>of</strong> a myelomeningocele is entirely<br />

reasonable. At the author's institution, patients who manifest ventriculomegaly after birth undergo<br />

shunt placement after myelomeningocele closure but while under the same anesthetic. Shunt<br />

placement not only decreases future anesthetic risk, but also it decreases the chance <strong>of</strong> CSF leaking<br />

through the myelomeningocele closure.<br />

Treatment <strong>of</strong> Chiari II malformations<br />

In CM II, decompression <strong>of</strong> the posterior fossa and/or cervical cord, with its variable anatomy, is<br />

surgically challenging and requires an experienced surgeon. The torcular can come in low near the<br />

foramen magnum, the cerebellum <strong>of</strong>ten is adherent to the medulla, and there are many venous<br />

sinuses. Catastrophic blood loss is the major risk when a sinus is inadvertently opened. Prior to<br />

decompressing a CM II, ensure the shunt is functioning. CT scan findings can be misleading, as<br />

ventricles can remain small despite an obstruction in the shunt. Shunt tap or exploration is the most<br />

reliable test prior to embarking on a Chiari decompression.<br />

The main signs and symptoms <strong>of</strong> a CM II that requires decompression are those <strong>of</strong> brainstem<br />

compression. For example, neonates can have stridor, central apnea, dysphagia, quadriparesis, or<br />

failure to thrive. Patients may have subtle signs, such as worsening strabismus, nystagmus,<br />

myelopathy, or aspiration <strong>of</strong> unclear etiology. Symptomatic CM II is the leading cause <strong>of</strong> death in our<br />

patients with myelomeningocele. (Approximately 30% <strong>of</strong> children die that develop brainstem<br />

symptoms when

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!